108 related articles for article (PubMed ID: 28143764)
1. Prostate-specific antigen density is predictive of outcome in suboptimal prostate seed brachytherapy.
Benzaquen D; Delouya G; Ménard C; Barkati M; Taussky D
Brachytherapy; 2017; 16(2):348-352. PubMed ID: 28143764
[TBL] [Abstract][Full Text] [Related]
2. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy.
Delouya G; Krishnan V; Bahary JP; Larrivée S; Taussky D
Urology; 2014 Sep; 84(3):629-33. PubMed ID: 25168545
[TBL] [Abstract][Full Text] [Related]
4. Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials.
Merrick GS; Wallner KE; Galbreath RW; Butler WM; Fiano R; Orio PF; Adamovich E
Brachytherapy; 2015; 14(5):677-85. PubMed ID: 26051802
[TBL] [Abstract][Full Text] [Related]
5. A comparison of early prostate-specific antigen decline between prostate brachytherapy and different fractionation of external beam radiation-Impact on biochemical failure.
Taussky D; Bedwani S; Meissner N; Bahary JP; Lambert C; Barkati M; Beauchemin MC; Ménard C; Delouya G
Brachytherapy; 2018; 17(2):277-282. PubMed ID: 29306674
[TBL] [Abstract][Full Text] [Related]
6. Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.
Mazeron R; Bajard A; Montbarbon X; Gassa F; Malet C; Rocher F; Clippe S; Bringeon G; Desmettre O; Pommier P
Radiat Oncol; 2012 Mar; 7():46. PubMed ID: 22449081
[TBL] [Abstract][Full Text] [Related]
7. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
Ciezki JP; Reddy CA; Garcia J; Angermeier K; Ulchaker J; Mahadevan A; Chehade N; Altman A; Klein EA
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):512-7. PubMed ID: 16213667
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy.
Tetreault-Laflamme A; Crook J; Hamm J; Pickles T; Keyes M; McKenzie M; Pai H; Bachand F; Morris J
J Urol; 2018 Jan; 199(1):120-125. PubMed ID: 28827105
[TBL] [Abstract][Full Text] [Related]
9. The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy.
Krishnan V; Delouya G; Bahary JP; Larrivée S; Taussky D
BJU Int; 2014 Dec; 114(6):865-71. PubMed ID: 24274784
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
[TBL] [Abstract][Full Text] [Related]
11. Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience.
Delouya G; Lambert C; Bahary JP; Beauchemin MC; Barkati M; Ménard C; Taussky D
Can J Urol; 2017 Jun; 24(3):8822-8826. PubMed ID: 28646937
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'.
Ahmed KA; Davis BJ; Mynderse LA; Slezak JM; Bergstralh EJ; Wilson TM; Choo CR
Radiat Oncol; 2014 Jul; 9():171. PubMed ID: 25074478
[TBL] [Abstract][Full Text] [Related]
13. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.
Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
Zelefsky MJ; Kuban DA; Levy LB; Potters L; Beyer DC; Blasko JC; Moran BJ; Ciezki JP; Zietman AL; Pisansky TM; Elshaikh M; Horwitz EM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):327-33. PubMed ID: 17084558
[TBL] [Abstract][Full Text] [Related]
15. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].
Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
Cancer Radiother; 2007 May; 11(3):105-10. PubMed ID: 17158082
[TBL] [Abstract][Full Text] [Related]
16. Does location of prostate cancer by sextant biopsies predict for relapse after (125)I seed implant brachytherapy?
Hill J; Hackett C; Sloboda R; Menon G; Singhal S; Pervez N; Pedersen J; Yee D; Murtha A; Amanie J; Usmani N
Brachytherapy; 2015; 14(6):788-94. PubMed ID: 26249125
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy.
Henry AM; Rodda SL; Mason M; Musunuru H; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):382-6. PubMed ID: 25805312
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy.
Patel N; Souhami L; Mansure JJ; Duclos M; Aprikian A; Faria S; David M; Cury FL
Brachytherapy; 2014; 13(5):450-5. PubMed ID: 25023396
[TBL] [Abstract][Full Text] [Related]
19. PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation.
McGrath SD; Antonucci JV; Fitch DL; Ghilezan M; Gustafson GS; Vicini FA; Martinez AA; Kestin LL
Brachytherapy; 2010; 9(2):137-44. PubMed ID: 19850537
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP
Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
